Dr. Alessandro Aiuti Receives the Else Kröner Fresenius Prize for Medical Research

ASGCT Staff - June 04, 2020

Dr. Aiuti has helped develop successful gene therapy approaches for diseases such as Wiskott-Aldrich Syndrome, metachromatic leukodystrophy, and ADA-SCID (Adenosine Deaminase Severe Combined Immuno Deficiency).

Alessandro Aiuti, M.D., Ph.D., has received the prestigious Else Kröner Fresenius Prize for Medical Research in the field of genome editing and gene therapy for his work on the advancement of therapies for immunodeficiencies and other genetic diseases.

The award honors researchers who have made significant scientific contributions to the field and whose work in the future can be expected to yield groundbreaking findings. Else Kröner-Fresenius-Stiftung is a non-profit foundation is dedicated to advancing medical research and medical-humanitarian projects.

Dr. Aiuti will receive 2.5 million euros, which include a personal prize of 500,000 euros and 2 million euros for his future research. Due to the COVID-19 pandemic, the prize was presented digitally. The award ceremony, which typically includes a scientific symposium with leaders in the field, has been postponed until May 31, 2021.

Dr. Aiuti is deputy director of clinical research at the San Raffaele Telethon Institute for Gene Therapy, and associate professor of pediatrics at Vita-Salute San Raffaele University, in Milan, Italy. He has been a member of ASGCT since 2003.


Share This Page